| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| MEDI-0618 | MEDI-0618; MEDI0618; ABBV-2002; ABBV2002 | Phase 2 Clinical | Astrazeneca Plc | Chronic Pain; Migraine Disorders | Details |
| TEV-56192 | TEV-56192 | Phase 1 Clinical | Teva Pharmaceutical Industries Ltd | Nervous System Diseases | Details |
| OA-235i | OA-235i | Phase 1 Clinical | Oasis Pharmaceuticals LLC | Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |